Moyamoya is a progressive arteriopathy of unknown origin affecting the branches of the internal carotid artery (ICA). The arteriopathy can present as an isolated medical condition, affecting both sides of the brain (“moyamoya disease”) or can be unilateral or found in association with systemic disorders (“moyamoya syndrome”). The ischemia resulting from luminal narrowing predisposes children to transient ischemic attacks and stroke—the primary presentations of affected patients. Although it is rare—affecting 1 in 1 million children in the US—moyamoya is implicated in 6% of all childhood strokes. Diagnosis is defined by characteristic findings on arteriograms, including stenosis of the branches of the ICA and a pathognomonic spray of small collateral vessels in this region, descriptively likened to a “puff of smoke” (“moyamoya” in Japanese). Treatment is predicated on restoration of cerebral blood flow by surgical revascularization. The rarity of this disorder has limited research and the development of evidence-based clinical management. While acknowledging these limitations, in this article the authors aim to summarize current studies of pediatric moyamoya, with the objective of providing a framework for construction of evidence-based guidelines for treatment. The compilation of current data in these guidelines should serve as a resource to aid pediatric neurosurgeons in their role as advocates for providing appropriate care to affected children.
Abbreviations used in this paper:ACA = anterior cerebral artery; AHA = American Heart Association; CCA = common carotid artery; CTA = CT angiography; ECA = external carotid artery; ICA = internal carotid artery; MCA = middle cerebral artery; MRA = MR angiography; STA = superficial temporal artery; TCD = transcranial Doppler; VA = vertebral artery.
Address correspondence to: Edward R. Smith, M.D., Department of Neurosurgery, Children's Hospital Boston, Hunnewell 2, 300 Longwood Avenue, Boston, Massachusetts 02115. email: firstname.lastname@example.org.
Please include this information when citing this paper: DOI: 10.3171/2011.12.PEDS1172.
FukuiM: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg99:Suppl 2S238–S2401997
HankinsonTCBohmanLEHeyerGLicursiMGhatanSFeldsteinNA: Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis. J Neurosurg Pediatr1:211–2162008
RoachESGolombMRAdamsRBillerJDanielsSDeveberG: Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke39:2644–26912008
ScottRMSmithJLRobertsonRLMadsenJRSorianoSGRockoffMA: Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg100:2 Suppl Pediatrics142–1492004
ShiraneRYoshidaYTakahashiTYoshimotoT: Assessment of encephalo-galeo-myo-synangiosis with dural pedicle insertion in childhood moyamoya disease: characteristics of cerebral blood flow and oxygen metabolism. Clin Neurol Neurosurg99:Suppl 2S79–S851997
TakeuchiSTanakaRIshiiRTsuchidaTKobayashiKAraiH: Cerebral hemodynamics in patients with moyamoya disease. A study of regional cerebral blood flow by the 133Xe inhalation method. Surg Neurol23:468–4741985
TanakaYNariaiTNagaokaTAkimotoHIshiwataKIshiiK: Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging—comparison with positron emission tomography. J Cereb Blood Flow Metab26:291–3002006